In vitro protective effects of Paeonia mascula subsp. hellenica callus extract on human keratinocytes.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
05 11 2020
05 11 2020
Historique:
received:
31
08
2020
accepted:
23
10
2020
entrez:
6
11
2020
pubmed:
7
11
2020
medline:
10
3
2021
Statut:
epublish
Résumé
Natural ingredients have been used to improve the state of health in humans. The genus Paeonia has been studied only limited yet it's reported to have many activities such as antioxidant and anti-inflammatory. To this context, here we focused on an endemic Paeonia species in Attica. This study aims to present the development of the Paeonia mascula subsp. hellenica callus extract and its pleiotropic bioactivity on human primary keratinocytes exploring its potential application as an active agent in skin-related products. This extract showed a high scavenging activity with high phenolic content and an interesting metabolic profile. At a molecular level, the study on the transcript accumulation of genes revealed that this extract exhibits in vitro skin-related protection properties by mediating mitochondrial energy, cell proliferation, immune and inflammatory response and positively regulates genes involved in epidermal and in stratum corneum function. Besides, the extract is proven not skin irritant on reconstructed human skin model. These findings indicate that the specific P. mascula subsp. hellenica extract possesses significant in vitro protection activity on human epidermis and provides new insights into its beneficial role in skin confirming that the advent of biotechnology contribution the past few decades.
Identifiants
pubmed: 33154501
doi: 10.1038/s41598-020-76169-0
pii: 10.1038/s41598-020-76169-0
pmc: PMC7645794
doi:
Substances chimiques
Plant Extracts
0
Protective Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
19213Commentaires et corrections
Type : ErratumIn
Références
Mol Aspects Med. 2013 Apr-Jun;34(2-3):516-28
pubmed: 23506886
J Immunol Methods. 1993 Mar 15;160(1):81-8
pubmed: 7680699
Molecules. 2014 Jun 11;19(6):7798-816
pubmed: 24962387
Proc Natl Acad Sci U S A. 1988 Mar;85(6):1937-41
pubmed: 2450352
J Invest Dermatol. 2001 Nov;117(5):1050-8
pubmed: 11710912
Genes Dis. 2018 Dec 31;6(1):16-24
pubmed: 30906828
Dermatoendocrinol. 2011 Apr;3(2):53-61
pubmed: 21695012
Biochim Biophys Acta. 2007 Sep-Oct;1769(9-10):546-58
pubmed: 17669516
FEBS Lett. 2006 Oct 9;580(23):5456-66
pubmed: 16962101
Mol Cell Endocrinol. 2004 Oct 15;225(1-2):119-25
pubmed: 15451576
J Dermatol Sci. 2019 Aug;95(2):50-55
pubmed: 31279501
Int J Mol Sci. 2019 May 30;20(11):
pubmed: 31151285
J Invest Dermatol. 2010 Oct;130(10):2511-4
pubmed: 20574438
Hum Mol Genet. 2013 Oct 15;22(20):4164-79
pubmed: 23748427
J Cell Biol. 2000 Feb 21;148(4):791-800
pubmed: 10684259
J Lipid Res. 2010 May;51(5):945-56
pubmed: 19965594
Nat Cell Biol. 2000 Dec;2(12):E231-6
pubmed: 11146675
J Invest Dermatol. 2016 Aug;136(8):1608-1616
pubmed: 27117051
J Funct Biomater. 2020 Apr 01;11(2):
pubmed: 32244595
Mol Cell Endocrinol. 2004 Oct 15;225(1-2):127-32
pubmed: 15451577
Biochim Biophys Acta. 2014 Mar;1841(3):295-313
pubmed: 24252189
Mol Biol Rep. 2020 Aug;47(8):5763-5772
pubmed: 32666439
Toxicol In Vitro. 2002 Oct;16(5):557-72
pubmed: 12206823
World J Gastroenterol. 2007 Jan 14;13(2):250-6
pubmed: 17226904
J Funct Biomater. 2020 Sep 03;11(3):
pubmed: 32899241
J Biol Chem. 2010 Mar 5;285(10):7300-11
pubmed: 20023287
J Immunol Res. 2017;2017:6976935
pubmed: 29250559
Inflamm Res. 2007 May;56(5):182-8
pubmed: 17588133
Trends Biochem Sci. 2009 Sep;34(9):453-63
pubmed: 19726197
Adv Exp Med Biol. 2016;901:59-76
pubmed: 26864271
Toxicol In Vitro. 1994 Aug;8(4):889-91
pubmed: 20693039
J Biomed Sci. 2016 Apr 12;23:38
pubmed: 27067525
J Cell Physiol. 2005 Mar;202(3):717-22
pubmed: 15389574
J Genet Eng Biotechnol. 2018 Dec;16(2):677-682
pubmed: 30733788
J Allergy Clin Immunol. 2009 Sep;124(3):496-506, 506.e1-6
pubmed: 19733297
J Invest Dermatol. 2002 Jul;119(1):166-73
pubmed: 12164940
Eur J Pharm Biopharm. 2017 Jul;116:149-154
pubmed: 28034807
J Drugs Dermatol. 2010 Jun;9(6 Suppl):S72-81; quiz s82-3
pubmed: 20626172
Chem Biodivers. 2010 Apr;7(4):805-38
pubmed: 20397219
Angew Chem Int Ed Engl. 1999 Jun 1;38(11):1532-1568
pubmed: 29710982
Trends Immunol. 2004 Dec;25(12):677-86
pubmed: 15530839
J Cell Biol. 2002 Mar 18;156(6):1099-111
pubmed: 11889141
Toxicol In Vitro. 2020 Aug;66:104869
pubmed: 32320759
Curr Med Chem. 2009;16(24):3152-67
pubmed: 19689289
Br J Dermatol. 2012 Jun;166(6):1245-54
pubmed: 22329734
Chem Pharm Bull (Tokyo). 2004 Mar;52(3):375-6
pubmed: 14993767
Molecules. 2017 Mar 23;22(4):
pubmed: 28333105
J Invest Dermatol. 2012 Mar;132(3 Pt 2):949-63
pubmed: 22217737
Antioxidants (Basel). 2019 Jul 27;8(8):
pubmed: 31357649
World J Gastroenterol. 2006 Jul 7;12(25):4078-81
pubmed: 16810764
J Ethnopharmacol. 2002 Jun;81(1):101-4
pubmed: 12020932
Nat Rev Mol Cell Biol. 2018 Mar;19(3):175-191
pubmed: 29165427
J Invest Dermatol. 2003 Apr;120(4):531-41
pubmed: 12648214
Science. 1992 Dec 11;258(5089):1798-801
pubmed: 1281554
Biomed Res Int. 2015;2015:643285
pubmed: 26064936
Fitoterapia. 2004 Jan;75(1):45-9
pubmed: 14693219
J Transl Med. 2013 Nov 02;11:277
pubmed: 24180516
Angew Chem Int Ed Engl. 2009;48(47):8848-69
pubmed: 19862781
J Korean Med Sci. 2007 Oct;22(5):862-7
pubmed: 17982236
Neurosci Lett. 2003 Mar 13;339(1):62-6
pubmed: 12618301
J Cell Mol Med. 2018 Sep;22(9):4507-4521
pubmed: 29993193